£685 / $1095 / €820
Tracking global drug developments in neurodegenerative disease; keeping you in touch with the latest product and research advances.
Neurodegenerative Drug News is a business news service that will keep you fully updated with the latest developments in neurodegenerative product registration, agreements and clinical trials.
Aged populations are expected to grow to unprecedented levels in the next 20 years, having a major impact on the incidence of neurodegenerative diseases. For example, according to the WHO, by 2025 there will be 34 million people worldwide with Alzheimer's disease. Consequently, industry attention is focusing as never before on the need to provide effective treatments.
Regular sections include:
Cost-effective multi-user distribution deals means the service can be used widely by colleagues in your organisation – contact sales at email@example.com for details, alternatively you can use our contact us page.